In addition, the agent bintrafusp alfa is able to bring the TGF-β trap to the tumor microenvironment through its anti-PD-L1 component, which simultaneously attacks both the immunosuppressive PD-L1 and TGF-β entities, resulting in anti-tumor effect (83). This evidence concerns the gene CD274 and neoplasm.